Rigel Pharmaceuticals Inc

RIGL

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001034842

SEC filings (opens in a new tab)

No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Rigel Pharmaceuticals Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of RIGL: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Of which not filed for Q2 2021	Q2 2021	Change
Holders	152	1	160	+9
Shares	144.2M	26.0K	141.6M	−2.58M (−1.8%)
Value	$493.1M	$89.0K	$614.5M	+$121.5M (+24.6%)

1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (25)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to RIGL in Q2 2021
Institution	Shares	Value	% of portfolio
Candriam Luxembourg S.C.A.	2,221,696	$9.64M	0.07%
Great Point Partners LLC	1,500,000	$6.51M	1.46%
Sio Capital Management, LLC	829,721	$3.60M	0.98%
Rubric Capital Management LP	663,856	$2.88M	0.18%
Schonfeld Strategic Advisors LLC	353,333	$1.53M	0.02%
Driehaus Capital Management LLC	343,000	$1.49M	0.02%
Gyon Technologies Capital Management, LP	264,330	$1.15M	0.38%
Summit Global Investments	223,700	$971.0K	0.06%
Tudor Investment Corp Et Al	143,966	$625.0K	0.01%
Jaffetilchin Investment Partners, LLC	92,931	$325.0K	0.02%
XTX Topco Ltd	36,878	$160.0K	0.05%
Pinz Capital Management, LP	30,000	$130.0K	0.04%
Ergoteles LLC	26,400	$115.0K	0.00%
Maven Securities LTD	25,907	$112.0K	0.01%
Group One Trading, L.P.	22,366	$97.0K	0.00%
Susquehanna Fundamental Investments, LLC	20,100	$87.0K	0.00%
Pictet Asset Management Ltd	19,004	$82.0K	0.00%
LPL Financial LLC	16,088	$70.0K	0.00%
Franklin Resources Inc	12,479	$54.0K	0.00%
Visionary Wealth Advisors	11,693	$51.0K	0.01%
State of Wyoming	1,752	$8.00K	0.01%
Eaton Vance Management	601	$3.00K	0.00%
Advisory Services Network, LLC	125	$1.00K	0.00%
American Portfolios Advisors	36	$156	0.00%
Loring Wolcott & Coolidge Fiduciary Advisors LLP	27	$0	0.00%

Sold out (16)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of RIGL in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Point72 Asset Management, L.P.	1,160,900	$3.97M
California Public Employees Retirement System	344,900	$1.18M
Renaissance Technologies LLC	220,500	$754.0K
Maverick Capital LtdSuperinvestorMaverick Capital	151,121	$517.0K
HSBC Holdings PLC	78,823	$269.0K
Dynamic Technology Lab Private Ltd	63,679	$218.0K
Virtu Financial LLC	38,459	$132.0K
Cubist Systematic Strategies, LLC	36,148	$124.0K
ExodusPoint Capital Management, LP	26,468	$91.0K
Wolverine Trading, LLC	17,883	$61.0K
Gsa Capital Partners LLP	16,043	$55.0K
Algert Global LLC	15,190	$52.0K
Pacer Advisors, Inc.	14,640	$50.0K
Point72 Hong Kong Ltd	1,360	$5.00K
Manchester Financial Inc	420	$1.00K
ShoreHaven Wealth Partners, LLC	100	$0

Not filed for Q2 2021 yet (1)

Institutions that held Rigel Pharmaceuticals Inc at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RIGL in Q1 2021 that haven't filed for Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
E Fund Management Co., Ltd.	26,028	$89.0K